BE1000535A4 - Composition pharmaceutique injectable a base d'amoxicilline. - Google Patents

Composition pharmaceutique injectable a base d'amoxicilline. Download PDF

Info

Publication number
BE1000535A4
BE1000535A4 BE8700157A BE8700157A BE1000535A4 BE 1000535 A4 BE1000535 A4 BE 1000535A4 BE 8700157 A BE8700157 A BE 8700157A BE 8700157 A BE8700157 A BE 8700157A BE 1000535 A4 BE1000535 A4 BE 1000535A4
Authority
BE
Belgium
Prior art keywords
sep
amoxicillin
injection
trihydrate
pharmaceutical composition
Prior art date
Application number
BE8700157A
Other languages
English (en)
French (fr)
Original Assignee
Bristol Myers Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Co filed Critical Bristol Myers Co
Application granted granted Critical
Publication of BE1000535A4 publication Critical patent/BE1000535A4/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/429—Thiazoles condensed with heterocyclic ring systems
    • A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
BE8700157A 1986-02-20 1987-02-20 Composition pharmaceutique injectable a base d'amoxicilline. BE1000535A4 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8602332A FR2594334B1 (fr) 1986-02-20 1986-02-20 Composition pharmaceutique injectable a base d'amoxicilline

Publications (1)

Publication Number Publication Date
BE1000535A4 true BE1000535A4 (fr) 1989-01-24

Family

ID=9332343

Family Applications (1)

Application Number Title Priority Date Filing Date
BE8700157A BE1000535A4 (fr) 1986-02-20 1987-02-20 Composition pharmaceutique injectable a base d'amoxicilline.

Country Status (13)

Country Link
BE (1) BE1000535A4 (xx)
CH (1) CH668706A5 (xx)
DE (1) DE3705349A1 (xx)
EG (1) EG18455A (xx)
ES (1) ES2003687A6 (xx)
FR (1) FR2594334B1 (xx)
GB (1) GB2186797B (xx)
GR (1) GR870278B (xx)
IT (1) IT1202567B (xx)
LU (1) LU86781A1 (xx)
MY (1) MY101146A (xx)
NL (1) NL8700416A (xx)
ZA (1) ZA871225B (xx)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2005215147B2 (en) * 2004-02-24 2011-05-26 Sandoz Ag Amoxicillin instant granulate
CN102614294B (zh) * 2011-01-27 2015-02-25 瑞普（天津）生物药业有限公司 一种复方阿莫西林混悬注射剂及其制备方法

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3969524A (en) * 1974-08-13 1976-07-13 Hoffmann-La Roche Inc. Stable amoxicillin dosage form
FR2302736A1 (fr) * 1975-03-07 1976-10-01 Beecham Group Ltd Composition antibiotique injectable
US4079131A (en) * 1975-01-02 1978-03-14 American Home Products Corporation Permanent suspension pharmaceutical dosage forms
EP0029668A1 (en) * 1979-11-08 1981-06-03 Beecham Group Plc Pharmaceutical injectable composition and two-pack container for said composition
EP0080862A1 (en) * 1981-12-02 1983-06-08 Beecham Group Plc Pharmaceutical formulation comprising beta-lactam antibiotics

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3969524A (en) * 1974-08-13 1976-07-13 Hoffmann-La Roche Inc. Stable amoxicillin dosage form
US4079131A (en) * 1975-01-02 1978-03-14 American Home Products Corporation Permanent suspension pharmaceutical dosage forms
FR2302736A1 (fr) * 1975-03-07 1976-10-01 Beecham Group Ltd Composition antibiotique injectable
EP0029668A1 (en) * 1979-11-08 1981-06-03 Beecham Group Plc Pharmaceutical injectable composition and two-pack container for said composition
EP0080862A1 (en) * 1981-12-02 1983-06-08 Beecham Group Plc Pharmaceutical formulation comprising beta-lactam antibiotics

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
CHEMICAL ABSTRACTS, vol. 89, no. 22, 27 novembre 1978, page 366, résumé no. 185963v, Columbus, Ohio, US; "Sterile amoxicillin trihydrate; sterile amoxicillin trihydrate for suspension", & FED. REGIST. 25-08-1978, 43(166), 38000-2 *
CHEMICAL ABSTRACTS, vol. 97, no. 20, 15 novembre 1982, page 370, résumé no. 168766f, Columbus, Ohio, US; UNITED STATES FOOD AND DRUG ADMINISTRATION: "Penicillin antibiotic drugs for animal use; sterile amoxicillin trihydrate for suspension", & FED. REGIST. 10-09-1982, 47(176), 39813 *

Also Published As

Publication number Publication date
MY101146A (en) 1991-07-31
GB2186797B (en) 1990-01-24
FR2594334A1 (fr) 1987-08-21
GB8703883D0 (en) 1987-03-25
NL8700416A (nl) 1987-09-16
EG18455A (en) 1992-12-30
GB2186797A (en) 1987-08-26
CH668706A5 (fr) 1989-01-31
IT8719426A0 (it) 1987-02-19
DE3705349A1 (de) 1987-08-27
FR2594334B1 (fr) 1990-01-12
LU86781A1 (fr) 1987-09-15
ZA871225B (en) 1987-10-28
ES2003687A6 (es) 1988-11-01
GR870278B (en) 1987-06-16
IT1202567B (it) 1989-02-09

Similar Documents

Publication Publication Date Title
EP0858329B1 (fr) Nouvelles formulations liquides stables a base de paracetamol et leur mode de preparation
KR102659761B1 (ko) Sglt-2 억제제를 포함하는 액상 약제학적 조성물
HU230300B1 (hu) Prosztaglandin E1 helyi beadásra alkalmas készítmények
CH667993A5 (de) Pharmazeutische formulierungen zur behandlung von gedaechtnisstoerungen.
CA2663387C (fr) Composition a base de xanthoxyline et son utilisation en cosmetique
US9114110B2 (en) Suspension type topical formulations comprising cyclic depdipeptide
AU616502B2 (en) Treatment of inflammatory disorders in humans
JP2008510003A5 (xx)
JP2013515020A (ja) 溶媒混合物およびビタミンｄ誘導体から成る医薬品組成物または類似体
BE1000535A4 (fr) Composition pharmaceutique injectable a base d'amoxicilline.
EP2200582B1 (fr) Utilisation d'excipients en tant que conservateurs et composition pharmaceutique les comprenant
FR2609394A1 (fr) Solution aqueuse contenant un acide quinolone carboxylique
AU2018392886B2 (en) Oral compositions and methods of use
WO2009007660A9 (fr) Compositions liquides ou pateuses destinees a l'apport en elements essentiels a la synthese et a la constitution des proteoglycanes, notamment pour le traitement de la degradation du cartilage
DE60103284T2 (de) Antifungizide zusammensetzung von ketoconazole zum auftragen
AT509777B1 (de) Adhesive retardformulierungen zur lokalen verabreichung von curcumin
CN116966129A (zh) 稳定的局部用非诺多泮组合物
EP0029790B1 (fr) Nouveau médicament à base d'aspirine et d'heptaminol
EP3197458B1 (fr) Utilisation dermocosmetique ou pharmaceutique d'une composition contenant au moins un inhibiteur de certaines cytokines chimio-attractantes
EP2938326B1 (fr) Nouvelles compositions pharmaceutiques veterinaires et leur procede de preparation
BE1026494B1 (fr) Procede ameliore de production de gel de podofilox
EP0635267A1 (fr) Compositions à base d'acides gras douées de propriétés anti-inflammatoires
EP0433140B1 (fr) Nouvelle préparation pharmaceutique anti-allergique à action prolongée
JP3027696B2 (ja) 安定な水性医薬組成物
CN102202671A (zh) 基于多拉克汀的长效口服生物粘附的杀体内寄生虫药凝胶组合物和用途

Legal Events

Date Code Title Description
RE20 Patent expired

Owner name: *BRISTOL-MYERS CY

Effective date: 20070220